Takeda Pharmaceutical Co Ltd (TAK): 6-K filed Aug 6, 2026

Form type

6-K

Filing date

Aug 6, 2026

Accession number

0001395064-26-000329

Filer

Takeda Pharmaceutical Co Ltd (CIK 1395064)